Description

Companies in the sector need to keep up with legal changes to continue capitalizing on commercial and business opportunities. During 2019, the pharmaceutical industry saw modifications in consolidated purchases of medicines and healing, radiological and laboratory materials. At the same time, permits granted to companies to market cannabis derivatives for medicinal use were revoked due to the lack of a legal framework.

In this chapter, the most important legal offices and consultants are interviewed to understand the challenges and opportunities in the health industry’s legal landscape. Experts in different regulatory areas highlight the different strategies companies should be implementing to minimize risk and make the most of their investment in times of change.

Title
Legal & Consulting
Number
13
Choose MBP Color
#566C11 0